Opened for input from May 10, 2021 to July 12, 2021.
Drug-device combination products (DDCPs) are health products that combine one or more drug components with one or more medical device components into one single integrated product. Health Canada is updating its policy on DDCPs to provide more detail and clarity on the classification and regulation of these products. As the first step, an Issue Identification Paper has been drafted to capture the outstanding issues with the current version of the policy.
Health Canada aims to engage with:
Through this consultation, Health Canada wants to make sure that key stakeholders:
We are seeking your input on the following themes:
The information gathered from this process will help to create a shared understanding of the issues associated with the existing policy and will inform the policy work to support its update.
Contact us by email: firstname.lastname@example.org